Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Merck's Busy Stretch Includes Collaborations With Dewpoint, Zymeworks

13 Jul 2020

• By Joseph Haas

DealWatch_1200x675

Related Content

Pacira Sees Big Opportunity In Exparel's Narrow Nerve Block Indication

10 Apr 2018

Deal Watch: Cigna Acquisition Of Express Scripts OKed By US Justice Dept.

17 Sep 2018

Mylan Shareholders Say Yes To Upjohn Merger

01 Jul 2020

Perrigo Bolsters US Generics Ahead Of Separation Plans

01 Jul 2020

Remdesivir Compulsory Licensing Is A Dead End For Europe

02 Jul 2020

Stada Will Continue To Invest To Drive Growth

03 Jul 2020

Caplin Partners With Xellia For Five Injectables

08 Jul 2020

Sandoz And Civica Rx Strike Five-Year Deal

09 Jul 2020

Deal Watch: Molecular Templates Aligns With Vertex On Optimizing Stem Cell Candidates

22 Nov 2019

Deal Watch: Celgene Reworks Alliance With Jounce, Gaining Global Rights To Macrophage-Targeting Candidate

01 Aug 2019

J&J To Power Ahead With 10 Launches In Four Years

17 Jan 2020

After Hemophilia Deal, UniQure Sees Zolgensma As Model For Huntington’s Gene Therapy

29 Jun 2020

uniQure Hemophilia B Deal With CSL Leaves M&A Fans Miffed

25 Jun 2020

G1 Believes Boehringer Is Better Bet To Sell Trilaciclib

01 Jul 2020

KKR Deal To Bolster JB Chemicals’ Expansion Efforts

03 Jul 2020

Kiadis And Sanofi Sign Natural Killer Cell Therapy Pact

08 Jul 2020

Anergis And Virometix Collaborate On Fast-Acting Allergy Immunotherapy

09 Jul 2020

Sanofi Nabs Kymera IRAK4 Protein Degrader As It Continues To Build In I&I

09 Jul 2020

Merck To Pay Up To $425m For Foghorn’s Gene Regulation Therapies

09 Jul 2020

Protein design firm Zymeworks in $187M deal with Merck for bi-specific antibodies

31 Aug 2011

Deal Watch: Valeant Sells Off iNova To Finance Debt-Reduction Efforts

15 Jun 2017

Civica Rx Partners With Kaiser Permanente

30 Jun 2020

Advanz Seeks To Build On European Platform

26 Jun 2020

Related Companies

Merck & Co., Inc.

Zymeworks, Inc.

Bristol Myers Squibb Company

Celgene Corporation

Dragonfly Therapeutics, Inc.

Gilead Sciences, Inc.

DURECT Corporation

Precision BioSciences, Inc.

Minerva Pharmaceutical S.A.

Johnson & Johnson

Pacira BioSciences, Inc.

DePuy Synthes

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

Twist Bioscience Corporation

Xencor, Inc.

Atreca, Inc.

Apeiron Biologics AG

MaxCyte, Inc.

UCB S.A.

Ferring Pharmaceuticals

Boehringer Ingelheim GmbH

Numab Therapeutics AG

Pfizer Inc.

Mission Therapeutics Ltd.

Hansa Biopharma AB

Oblique Therapeutics AB

Additional Topics

Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.